Siplizumab: A Deep Investigation into MEDI-507 and 288392-69-8 Siplizumab, previously recognized as MEDI-507 and bearing the compound designation 288392-69-8, represents a unique antibody designed to selectively target https://dawudvyon721762.wikiannouncement.com/user